E. Lonn

Early initiation of sacubitril/valsartan in patients with acute heart failure and renal dysfunction: An analysis of the TRANSITION study.

M. Senni, A. Noè, H. Schwende, 2023, Journal of cardiac failure.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

P. Pais, Á. Avezum, A. Parkhomenko, 2016, Journal of the American Heart Association.